Homosexuality: Clinical Trials

9 trials for Homosexuality, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown, 1 withdrawn. 9 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 7, Unknown 1, Withdrawn 1
Phase 13Completed 2, Withdrawn 1
Phase 33Completed 3

Follow Homosexuality: new trials by email Literature Review of Homosexuality trials Research Report on Homosexuality

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
9-valent HPV vaccination - Anal Intraepithelial Neoplasia, Anal Cancer
Phase 2UnknownUniversity Health Network, Toronto2282022-09-012022-06-13
Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men
Mobile Phone Application - Depressive Symptoms, Anxiety Generalized
Phase 1 / Phase 2WithdrawnNorthwestern University2017-08-142017-08-17
Stonewall Treatment Evaluation Project
Stonewall Project - Substance Abuse, HIV Infections
Phase 1 / Phase 2CompletedUniversity of California, San Francisco1502010-03-012014-10-27
No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks
Video (group-delivered video-based intervention), HCT - HIV Infections
Phase 2 / Phase 3CompletedCenters for Disease Control and Prevention3702008-06-012010-03-09
Men of African American Legacy Empowering Self
Men of African American Legacy Empowering Self, Standard HIV Education & Risk Reduction - HIV
Phase 2CompletedCharles Drew University of Medicine and Science4372007-08-012014-06-11
Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM
Many Men, Many Voices (3MV) - HIV Infections, Sexually Transmitted Diseases
Phase 1 / Phase 2CompletedCenters for Disease Control and Prevention3412005-08-012010-06-24
Voucher-Based Incentives in a Prevention Setting
Voucher-Based Reinforcement Therapy - Substance-related Disorders
Phase 2 / Phase 3CompletedFriends Research Institute, Inc.1312005-04-012013-08-01
Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Network leader training, Standard HIV risk-reduction counseling - HIV Infections
Phase 2CompletedMedical College of Wisconsin8522004-07-012011-11-11
Community Intervention Trial for Youth (CITY) Study
Community-Level Intervention - HIV Infections
Phase 2 / Phase 3CompletedCenters for Disease Control and Prevention120001996-10-012012-09-27

Narrower conditions

HIV Infections (5)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Homosexuality, Male (2)  ·  Substance-Related Disorders (2)  ·  Alzheimer Disease (1)  ·  Anus Neoplasms (1)  ·  Anxiety Disorders (1)  ·  Bisexuality (1)  ·  Depression (1)  ·  Generalized Anxiety Disorder (1)  ·  Multiple Endocrine Neoplasia Type 1 (1)  ·  Risk-Taking (1)  ·  Safe Sex (1)  ·  Sexual Behavior (1)

Broader conditions

Behavior (9)  ·  Sexuality (9)  ·  Sexual Behavior (8)  ·  Blood-Borne Infections (6)  ·  Communicable Diseases (6)  ·  Genital Diseases (6)  ·  Immune System Diseases (6)  ·  Immunologic Deficiency Syndromes (6)  ·  Infections (6)  ·  Lentivirus Infections (6)  ·  RNA Virus Infections (6)  ·  Retroviridae Infections (6)  ·  Sexually Transmitted Diseases, Viral (6)  ·  Urogenital Diseases (6)  ·  Virus Diseases (6)

Interventions

Videotape Recording (1)

Sponsors

Centers for Disease Control and Prevention (3)  ·  Charles Drew University of Medicine and Science (1)  ·  Friends Research Institute, Inc. (1)  ·  Medical College of Wisconsin (1)  ·  Northwestern University (1)  ·  University Health Network, Toronto (1)  ·  University of California, San Francisco (1)

Countries

United States (8)  ·  Canada (1)

Top investigators

Adam W Carrico, Ph.D. (1)  ·  Carol L. Galletly, JD, PhD (1)  ·  Carolyn A Guenther-Grey, M.A. (1)  ·  Cathy J Reback, Ph.D. (1)  ·  Cleo Manago (1)  ·  David W. Seal, PhD (1)  ·  Irving Salit, MD (1)  ·  Jeffrey A. Kelly, PhD (1)  ·  Jeffrey H Herbst, PhD (1)  ·  Jesse B Fletcher, Ph.D. (1)  ·  John K. Williams, MD (1)  ·  Kevin Pickett (1)  ·  Laura R. Glasman, PhD (1)  ·  Lydia O'Donnell, PhD (1)  ·  Michael D. Siever, Ph.D. (1)

Results publications

PMID 19267264, PMID 20667681, PMID 21128876, PMID 22880545, PMID 24180003, PMID 24743663, PMID 27516073

NIH funding

K08MH094441 (1), P20MD000182 (1), R01DA015990 (1), R01MH070316 (1)